GeneDx Holdings Corp (NASDAQ:WGS)’s traded shares stood at 1.1 million during the last session, with the company’s beta value hitting 1.99. At the close of trading, the stock’s price was $101.00, to imply an increase of 1.89% or $1.87 in intraday trading. The WGS share’s 52-week high remains $115.60, putting it -14.46% down since that peak but still an impressive 92.49% since price per share fell to its 52-week low of $7.59.
Analysts have given a consensus recommendation of Buy for GeneDx Holdings Corp (WGS), translating to a mean rating of 2.00. Of 3 analyst(s) looking at the stock, 0 analyst(s) give WGS a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 3 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.11.
GeneDx Holdings Corp (NASDAQ:WGS) trade information
After registering a 1.89% upside in the last session, GeneDx Holdings Corp (WGS) has traded red over the past five days. The 5-day price performance for the stock is -0.57%, and 27.46% over 30 days. With these gigs, the year-to-date price performance is 31.41%.
The extremes give us $70 and $70 for target low and target high price respectively. As such, WGS has been trading 30.69% off suggested target high and 30.69% from its likely low.
GeneDx Holdings Corp (WGS) estimates and forecasts
The rating firms project that company’s revenue will grow 17.40% compared to the previous financial year.
Revenue forecast for the current quarter as set by 6 analysts is 79.9M. Meanwhile, for the current quarter, a total of 6 analyst(s) estimate revenue growth to 85.32M.Earnings reports from the last fiscal year show that sales brought in 62.42M and 70.51M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 27.99% before jumping 20.99% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 96.65% for the past 5-year period. While 2025 is set for a 248.68% return in earnings, projections for the next 5 years are at 119.03% annually.
WGS Dividends
GeneDx Holdings Corp has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is CORVEX MANAGEMENT LP with 2.47 million shares, or about 9.2937% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $64.66 million.
